Impaired coronary flow reserve in patients with metastatic cancer treated with sunitinib. Impact of the chronic kidney disease epidemiology collaboration (CKD-EPI) equation for estimating renal ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
(Toronto, Dec. 5, 2022) – The Ajmera Transplant Centre at University Health Network (UHN) has performed a groundbreaking parathyroid transplant, in a patient who suffered from a severe form of ...
COPENHAGEN, Denmark, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improvements in renal function ...
Mechanisms governing the antagonistic bone-promoting and bone-resorbing effects of parathyroid hormone induction are unclear. New study by researchers from Tokyo University of Science reveals a novel ...
Researchers have developed the first patient-derived parathyroid organoid (PTO), which accurately mimics parathyroid structure and function and could improve in vitro research and drug development.
COPENHAGEN, Denmark, July 14, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced new data from Week 156 of its Phase 3 PaTHway Trial confirming that long-term treatment with TransCon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results